🇺🇸 FDA
Pipeline program

TL011

NHL-TL011-102

Phase 1 mab completed

Quick answer

TL011 for DLBCL is a Phase 1 program (mab) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
DLBCL
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials